Jia Yuan Tong

Dr. Jia Yuan Tong is an Independent Director at Horizon Space Acquisition II Corp., an Independent Director at Jin Medical International Ltd. and an Independent Director at Papa Medical, Inc. He is on the Board of Directors at Horizon Space Acquisition II Corp., Xynomic Pharmaceuticals, Inc., Jin Medical International Ltd. and Papa Medical, Inc. Dr. Tong was previously employed as a Director & Partner by Korea Investment Partners Co., Ltd., an Executive Director, Chief Strategy Officer & EVP by Xynomic Pharmaceuticals Holdings, Inc., a Chief Executive Officer & Director by Bison Capital Acquisition Corp., a Partner by Bison Capital Holding Co., Ltd., a Partner by Delta Capital Investments (California), a Chief Financial Officer & Director by Tianyin Pharmaceutical Co., Inc., a Research Analyst by ROTH Capital Partners LLC, a Research Associate by Rodman & Renshaw LLC (Old), a Principal Investigator by The Marine Biological Laboratory, a Founder by Thorbay Holdings, and a Senior Research Fellow by University of California, Irvine.
He received his undergraduate degree from Peking University and a doctorate degree from Stony Brook University.